Regulatory aspects for Biologic Product licensing in Australia
Journal Title: International Journal of Drug Regulatory Affairs - Year 2019, Vol 7, Issue 2
Abstract
The TG Act defines biological as product made, from or containing, human cells or human tissues, lives animal organs, cells or tissues, and that is used to treat or prevent disease or injury, Diagnose a condition of a person and Alter the physiological processes of a person. The Australian Regulatory Guidelines for Biologicals (ARGB) provide the keen information for manufacturers, sponsors, professionals in healthcare and also to public about the use of human cells and tissues based therapeutic goods, live animal cells, organs and tissues (1). These all products are Biologicals. This guideline is specially written for general public. If you are a sponsor or manufacture, this will: • Explains the biological regulatory framework is applies to manufacturer’s product and their exemption conditions (1). • Explains the Australian regulatory requirements for supplying of Biologicals • Explains what is required for the market authorization as per TGA especially for Biologicals.
Authors and Affiliations
Sanjeev Kumar Maurya, Vikesh Kumar Shukla, Sunny Kumar Maurya, Prachi Kaushik, Indu Maurya
Keywords
Related Articles
- EP ID EP625605
- DOI 10.22270/ijdra.v7i2.310
- Views 117
- Downloads 0
AN OVERVIEW OF CHINESE DRUG REGULATORY SYSTEM: A REVIEW
The Drug regulatory authority of China was renewed from state pharmaceutical administration of China (SPAC) to state food and Drug administration (SFDA) with the announcement and declaration of Chinese ministry of health...
SCALE UP AND POSTAPPROVAL CHANGES (SUPAC) GUIDANCE FOR INDUSTRY: A REGULATORY NOTE
In today scenario, as per market demand there is definitely carry out an increment or decrease in production, this is called SUPAC. Different guidelines are provided for those different types of SUPAC in by different reg...
Regulatory requirements for Vaccine registration in United States
Vaccination is one among the foremost cost-efficient health interventions out available, saving a lot of individuals from illness, incapacity, and death annually. No alternative countermeasures are effective in reducing...
PIC/S: TRAINING THE REGULATORS TO REGULATE cGMP COMPLIANCE
PIC/S is an international Organization for implementing cGMP standards in its member countries. The basic objective of PIC/S is to improve and standardize cGMP compliance in member countries. Their aim is to enhance GMP...
THE NEW REGULATIONS FOR THE APPROVAL OF MEDICINAL PRODUCTS IN IVORY COAST: APPLICATION OF REGULATION N ° 06/2010 / CM / WAEMU RELATING TO PROCEDURES FOR THE APPROVAL OF PHARMACEUTICAL PRODUCTS FOR HUMAN USE IN WAEMU MEMBER STATES
Harmonization of procedures for the approval of medicines in the WAEMU area allows Member States to have a standard tool for the examination of applications for marketing authorization for medicinal products for human us...